Also the second most common endocrine disorder affecting women of reproductive age, and when untreated during pregnancy is associated with an increased risk of miscarriage, placental abruption, hypertensive disorders, and growth restriction. Current guidelines recommend targeted screening of women at high risk, including those with a history of disease, type 1 diabetes mellitus, or other autoimmune disease; current or past use or a family history of autoimmune.
Basically appropriate management results in improved outcomes, demonstrating the importance of proper diagnosis and treatment. In women with hypothyroidism, levothyroxine is titrated to achieve a goal serum stimulating hormone level less than 2.5 mIU per L. The preferred treatment is antithyroid medications, with a goal of maintaining a serum free thyroxine level in the upper one-third of the normal range.
Also Postpartum is the most common form of postpartum dysfunction and may present as hyper. Symptomatic treatment is recommended for the former; levothyroxine is indicated for the latter in women who are symptomatic, breastfeeding, or who wish to become pregnant.